The jury found Monday that Genentech breached its 1976 contract with the medical center and acted with fraud or malice in withholding certain royalty payments. The jury is to reconvene June 17 to decide whether Genentech should pay punitive damages and, if so, how much.

The jury reached its decision after 16 days of deliberation. It is the second time the case went before a jury. In October the first jury deadlocked, resulting in a mistrial. The retrial began in March.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]